Integra Announces Completion of Refinancing Transactions

Related news

Integra LifeSciences to Highlight ENT and Instruments Portfolios and Sponsor New Clinical Research Presentations at AAO-HNSF 2026 Annual Meeting

EHCEncompass Health Corporation2026-08-10 20:30 EST

Encompass Health prices private offering of additional 5.875% senior notes due 2034

EHCEncompass Health Corporation2026-08-10 12:28 EST

Encompass Health announces launch of private offering of 5.875% senior notes due 2034

FEMYFEMASYS2026-08-07 13:25 EST

Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million

PAVMPAVmed2026-10-22 20:20 EST

Lucid Diagnostics Begins Receiving Medicare Reimbursement for EsoGuard® and Closes $15 Million Financing

JNJJohnson & Johnson2026-08-21 09:40 EST

European Commission approves Johnson & Johnson’s TECVAYLI®▼ (teclistamab) plus daratumumab for relapsed/refractory multiple myeloma, offering a potential new standard of care

View all latest news

Integra LifeSciences

Medical Technology Portfolio Integra LifeSciences develops medical technologies used in neurosurgery, reconstructive surgery and wound care. Its products support procedures in which tissue protection, repair and regeneration are critical to patient outcomes. Neurosurgical Technologies The company supplies instruments, implants and...